ArticleClinical, cosmetic and investigational dermatology2025
Hydrocolloid versus Liquid Dressings for Incontinence-Associated Dermatitis: A Clinical Evaluation in Critically Ill Patients.
Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study was to compare the clinical efficacy of liquid and hydrocolloid dressings in the management of incontinence-associated dermatitis (IAD) among critically ill patients and to evaluate their effects on skin lesion healing, symptom improvement, and complication prevention. Methods: A total of 136 critically ill patients diagnosed with IAD and admitted to the hospital between January 2023 and January 2024 were included. Patients were randomly assigned using the random number table method to the hydrocolloid dressing group (n = 68) or the liquid dressing group (n = 68). The hydrocolloid dressing group received DuoDERM Results: Following treatment, SCORAD, DLQI, PAT, and VAS scores decreased significantly in both groups compared with baseline (all Conclusion: For critically ill patients with IAD, hydrocolloid dressings demonstrated superior efficacy compared with liquid dressings. Hydrocolloid dressings promoted faster healing of skin lesions, decreased recurrence and complication rates, and improved overall clinical outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.